Related Experiment Video
Updated: Feb 4, 2026

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Targeted Hydroxyurea Education after an Emergency Department Visit Increases Hydroxyurea Use in Children with Sickle
Lydia H Pecker1, Sarah Kappa2, Adam Greenfest3
1Division of Hematology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD.
Insights
An initiative to increase hydroxyurea use in children with sickle cell anemia (SCA) significantly boosted treatment initiation and adherence. This approach improved hydroxyurea uptake in eligible patients presenting to the emergency department (ED).
Area of Science:
- Hematology
- Pediatric Medicine
- Public Health Initiatives
Background:
- Sickle cell anemia (SCA) is a serious condition requiring effective management.
- Hydroxyurea is a crucial treatment for SCA, but its uptake can be challenging.
- Emergency department (ED) visits present opportunities to initiate or optimize SCA treatment.
Purpose of the Study:
- To assess the effectiveness of a targeted initiative in increasing hydroxyurea use among pediatric SCA patients.
- To evaluate the impact of the Quick-Start Hydroxyurea Initiation Project (Q-SHIP) on hydroxyurea initiation and adherence.
- To determine if Q-SHIP participation influences hydroxyurea use compared to non-participants.
Main Methods:
- An observational cohort study was conducted involving children with SCA presenting to the ED without hydroxyurea.
- Eligible patients attended a Q-SHIP session, featuring expert discussion, patient testimonials, and an immediate offer to start hydroxyurea.
- Hydroxyurea initiation, adherence, and relevant laboratory markers (mean corpuscular volume, hemoglobin F) were tracked.
Main Results:
- 59% of eligible ED patients participated in Q-SHIP, with 55% starting hydroxyurea.
- Hydroxyurea adherence was high (83%) among those who started the medication, supported by increased mean corpuscular volume and hemoglobin F levels.
- Q-SHIP participants were significantly more likely to start and continue hydroxyurea compared to non-participants, leading to an overall increase in hydroxyurea use from 56% to 80% in eligible ED patients.
Conclusions:
- A dedicated clinic session focused on initiating hydroxyurea after an SCA complication effectively increases its use.
- The Q-SHIP model demonstrates success in improving hydroxyurea initiation and sustained use in pediatric SCA patients.
- Targeted interventions in the ED setting can significantly enhance adherence to essential SCA therapies.
Objective:
To evaluate the impact of an initiative to increase hydroxyurea use among children with sickle cell anemia (SCA) who presented to the emergency department (ED).
Study Design:
This observational cohort study included children with SCA not taking hydroxyurea who presented to the ED with pain or acute chest syndrome and then attended a Quick-Start Hydroxyurea Initiation Project (Q-SHIP) session. A Q-SHIP session includes a hematologist-led discussion on hydroxyurea, a video of patients talking about hydroxyurea, and a direct offer to start hydroxyurea.
Results:
Over 64 weeks, 112 eligible patients presented to the ED and 59% (n = 66) participated in a Q-SHIP session a median of 6 days (IQR 2, 20 days) after ED or hospital discharge; 55% of participants (n = 36) started hydroxyurea. After a median follow-up of 49 weeks, 83% (n = 30) of these participants continued hydroxyurea. Laboratory markers of hydroxyurea adherence were significantly increased from baseline: median mean corpuscular volume +8.6 fL (IQR 5.0, 17.7, P < .0001) and median hemoglobin F +5.7% (IQR 2.5, 9.8, P = .0001). Comparing Q-SHIP participants to nonparticipants, 12 weeks after ED visit, participants were more likely to have started hydroxyurea than nonparticipants (53% vs 20%, P = .0004) and to be taking hydroxyurea at last follow-up (50% vs 20%, P = .001). Two years after the implementation of Q-SHIP the overall proportion of eligible patients on hydroxyurea presenting to our ED increased from 56% to 80%, P = .0069.
Conclusions:
Participation in a clinic to specifically address starting hydroxyurea after a SCA complication increases hydroxyurea use.
More Related Videos
Related Concept Videos
Emerging Adulthood
Increasing Function
Introduction Cardiac Emergencies
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Types of Records II: Educational and Administrative Records

